News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
618,729 Results
Type
Article (58708)
Company Profile (187)
Press Release (559834)
Section
Business (169649)
Career Advice (1834)
Deals (28961)
Drug Delivery (95)
Drug Development (65711)
Employer Resources (148)
FDA (14335)
Job Trends (13754)
News (285476)
Policy (27951)
Tag
Academia (2892)
Alliances (47660)
Alzheimer's disease (1257)
Approvals (14354)
Artificial intelligence (210)
Bankruptcy (220)
Best Places to Work (11210)
Biotechnology (109)
Breast cancer (201)
Cancer (1505)
Cardiovascular disease (112)
Career advice (1543)
Cell therapy (314)
Clinical research (52006)
Collaboration (651)
Compensation (149)
COVID-19 (2602)
C-suite (145)
Data (1470)
Diabetes (181)
Diagnostics (6300)
Earnings (59946)
Employer resources (129)
Events (98232)
Executive appointments (542)
FDA (15162)
Funding (584)
Gene therapy (216)
GLP-1 (553)
Government (4578)
Healthcare (18759)
Infectious disease (2711)
Inflammatory bowel disease (109)
Interviews (330)
IPO (12899)
Job creations (3006)
Job search strategy (1335)
Layoffs (317)
Legal (5800)
Lung cancer (217)
Manufacturing (211)
Medical device (12568)
Medtech (12573)
Mergers & acquisitions (16455)
Metabolic disorders (471)
Neuroscience (1611)
NextGen: Class of 2025 (6506)
Non-profit (4827)
Northern California (1801)
Obesity (256)
Opinion (181)
Patents (128)
People (50215)
Phase I (16389)
Phase II (22085)
Phase III (17390)
Pipeline (641)
Postmarket research (2420)
Preclinical (7632)
Radiopharmaceuticals (225)
Rare diseases (272)
Real estate (5475)
Regulatory (19109)
Research institute (2598)
Resumes & cover letters (261)
Southern California (1521)
Startups (3223)
United States (16525)
Vaccines (622)
Weight loss (161)
Date
Today (13)
Last 7 days (540)
Last 30 days (2321)
Last 365 days (31125)
2025 (4085)
2024 (31771)
2023 (35935)
2022 (46903)
2021 (51321)
2020 (50725)
2019 (45175)
2018 (33953)
2017 (28684)
2016 (29244)
2015 (34597)
2014 (27239)
2013 (23818)
2012 (24310)
2011 (24988)
2010 (23152)
Location
Africa (828)
Arizona (163)
Asia (40536)
Australia (6848)
California (4058)
Canada (1567)
China (345)
Colorado (203)
Connecticut (230)
Europe (84081)
Florida (637)
Georgia (165)
Illinois (433)
Indiana (260)
Japan (119)
Maryland (669)
Massachusetts (3091)
Michigan (205)
Minnesota (306)
New Jersey (1265)
New York (1242)
North Carolina (798)
Northern California (1801)
Ohio (161)
Pennsylvania (980)
South America (1061)
Southern California (1521)
Texas (589)
Utah (142)
Washington State (439)
618,729 Results for "quintiles hrs formerly health research solutions pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Sentrex Health Solutions Inc. Expands Innovative Healthcare Services with Strategic Acquisition of PerCuro Clinical Research Ltd.
Sentrex Health Solutions Inc., a leading provider of specialty healthcare services in Canada, is excited to announce the acquisition of PerCuro Clinical Research Ltd.—one of Canada’s premier providers of infusion services, clinical research, and advanced nursing care.
February 12, 2024
·
2 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Press Releases
IncreMedical Therapy Solutions Rebrands as Confluent Health System Solutions to Advance Musculoskeletal Rehabilitation Services Nationwide
February 6, 2025
·
3 min read
Business
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that its Australian subsidiary, Psyence Australia Pty Ltd. (“Psyence Australia”), has entered into a partnership with Fluence, a global leader in professional education and training for psychedelic therapy research, and iNGENū CRO Pty Ltd (“iNGENū”), an Australian clinical research organization (CRO), to support an upcoming Phase llb clinical trial.
April 8, 2024
·
8 min read
CARTHERICS ENTERS INTO COLLABORATIVE RESEARCH AGREEMENT WITH TICAROS
Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has entered a collaborative research agreement with TiCARos Co Ltd
April 2, 2024
·
4 min read
Press Releases
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
February 19, 2025
·
2 min read
BioMidwest
Research on Plant-Based SARS-CoV-2 Vaccine to Be Presented at One Health Symposium by PlantPharm BioMed
Dr. Richard Matner, President of PlantPharm BioMed, Ltd. will be presenting at the International Symposium on One Health Research: Improving Food Security and Resilience, in Galveston, Texas April 21–23, 2024.
April 15, 2024
·
2 min read
Press Releases
Digital Health Market Set to Surge to USD 1,093.65 Billion by 2034 Says Precedence Research
February 11, 2025
·
1 min read
Press Releases
Flatiron Health Announces Upcoming Research Presentations at the San Antonio Breast Cancer Symposium 2024
December 4, 2024
·
4 min read
Business
BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation, and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers.
February 27, 2024
·
3 min read
1 of 61,873
Next
